Abstract:Purpose: As a novel imaging modality, x-ray fluorescence computed tomography (XFCT) can provide distribution and concentration information of contrast agents containing high atomic number elements, such as iodine, gadolinium, barium, gold, and platinum. Since XFCT has a better sensitivity and detection limit of high-Z elements compared with traditional and spectral CT, it becomes a powerful quantitative imaging tool for biological studies. The main problem of current XFCT imaging is its low emission and detection efficiency of x-ray fluorescence (XRF) photons. Increasing XRF photons generation by choosing a high atomic element as a contrast agent is essential to improve the imaging quality of XFCT. Gadolinium emits at least a few times more of XRF photons than gold under the same x-ray excitation condition, leading to a detection limit at a level of sub-mg/mL as the next generation of clinical imaging modality. However, most current XFCT studies have utilized gadolinium salt as the contrast agent, which could not accumulate in organs or tumors efficiently, making in vivo XFCT imaging quite difficult. In this study, we present NaGdF4 nanoparticles with ultra-small size as nanoprobes to test the feasibility for in vivo XFCT application for the first time. Methods: NaGdF4 nanoparticles with different sizes (3-10 nm) were successfully synthesized via a coprecipitation process by controlling the reaction time at temperature of 290 °C. The morphology, crystal phase, chemical composition, and size of such NPs were further characterized with HR-TEM, XRD, and EDX. The abilities of XRF photons from different sizes of NPs were quantified by our customized XFCT imaging system. To access the in vivo application of as-synthesized NPs, such hydrophobic NPs capped OA molecules were further modified with AEP via a ligand-exchange process and characterized with FT-IR. For in vivo XFCT imaging, 0.1 mL of 30 mg/mL NPs were injected into nude mice via the tail vein. The Varian G-297 x-ray tube was set to 150 kV and 0.5 mA. The XRF photons were captured by a Kromek eV-3500 photon counting detector at each 8° for 10 s. Result: The successfully synthesized NaGdF4 nanoparticles (3-10 nm) were monodisperse, highly uniform spherical morphology and hexagonal crystalline phases. No significant influence on XRF photons yields or XFCT imaging quality were found by varying the nanoparticle size. The XRF photons were 2.5 times more emitted from NaGdF4 nanoparticles (NPs) compared to gold nanoparticles, thereby leading to a better image quality. With the AEP surface modification, such NPs were readily adapted for use in in vivo XFCT applications with monodispersity in aqueous solution and negligible cytotoxicity. With the tail-vein injection, the liver, spleen, and lungs could be clearly imaged with XFCT at a sub-mg/mL level. Conclusions: Such NaGdF4 NPs, which were synthesized with coprecipitation process, were modified with AEP for in vivo XFCT applications. With both the phantom and in vivo experiments, such NPs were proved to be appropriate probes for XFCT application with the detection limit at a sub-mg/mL level. In the future research, such NPs could be further functionalized with targeting molecules for early-phase cancer detection.

Size-controlled synthesis of gold nanoparticles and related molecular imaging contrast for computed tomography

Synthesis and Properties of Ag‐Au Alloy Nanoparticles with Controlled Composition for Computed Tomography Imaging Applications

Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents.

Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics

Sub-10 Nm Water-Dispersible Β-Nagdf4:X% Eu3+ Nanoparticles with Enhanced Biocompatibility for in Vivo X-ray Luminescence Computed Tomography

Gold nanoparticles spectral CT imaging and limit of detectability in a new materials contrast-detail phantom

Effect of Computed Tomography Scanning Parameters on Gold Nanoparticle and Iodine Contrast

X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer

Poly(Acrylic Acid) Bridged Gadolinium Metal-Organic Framework-Gold Nanoparticle Composites As Contrast Agents for Computed Tomography and Magnetic Resonance Bimodal Imaging

GOLD AND SILVER NANOPARTICLES AS COMPUTED TOMOGRAPHY (CT) CONTRAST AGENTS PRODUCED BY A PULSED LASER ABLATION TECHNIQUE: STUDY In-vitro AND In-vivo

Development of Gold Nanoparticles Coated with Bismuth Oxide for X-ray Computed Tomography Imaging

Construction of ultrasmall gold nanoparticles based contrast agent via Host-Guest interaction for Tumor-targeted magnetic resonance imaging

The feasibility of NaGdF4 nanoparticles as an x-ray fluorescence computed tomography imaging probe for the liver and lungs

Chain-like gold nanoparticle clusters for multimodal photoacoustic microscopy and optical coherence tomography enhanced molecular imaging

Recent Development of Gold Nanoparticles as Contrast Agents for Cancer Diagnosis

Facile Photochemical Synthesis and Characterization of Highly Luminescent Gold Nanoparticles as Versatile Probes for Bioimaging Applications

Thin Layer-Protected Gold Nanoparticles for Targeted Multimodal Imaging with Photoacoustic and CT

Advances in Multifunctional Nano-Sized CT Contrast Agents

Engineering and quantification of bismuth nanoparticles as targeted contrast agent for computed tomography imaging in cellular and animal models

Fabrication of folic acid–cysteamine-modified silver nanoparticles as promising contrast agent for computed tomography imaging

Optimization of the Composition of Bimetallic Core/shell Fe 2 O 3 /au Nanoparticles for MRI/CT Dual-Mode Imaging